Caricamento...

Therapeutic Activity of Lenalidomide in Mantle Cell Lymphoma and Indolent Non-Hodgkin's Lymphomas

Mantle cell lymphoma (MCL) comprises 3–10% of NHL, with survival times ranging from 3 and 5 years. Indolent lymphomas represent approximately 30% of all NHLs with patient survival largely dependent on validated prognostic scores. High response rates are typically achieved in these patients with curr...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Gunnellini, Marco, Falchi, Lorenzo
Natura: Artigo
Lingua:Inglês
Pubblicazione: Hindawi Publishing Corporation 2012
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3384930/
https://ncbi.nlm.nih.gov/pubmed/22761620
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2012/523842
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !